Treatment of iron deficiency in patients with chronic kidney disease: A prospective observational study of iron isomaltoside (NIMO Scandinavia)
.

ABSTRACT:

Aims

Iron deficiency is common in patients with chronic kidney disease (CKD). Appropriate iron substitution is critical and intravenous iron is an established therapy for these patients. The objective of this study was to assess treatment routine, -effectiveness, and safety of iron isomaltoside (Monofer^®, Pharma-cosmos A/S, Holbaek, Denmark) in CKD patients in clinical practice.

Materials and methods

This was a prospective observational study conducted in predialysis CKD patients treated with iron isomaltoside according to the product label and to routine clinical care.

Results

The study included 108 patients with predialysis CKD: 22 were in stage 2 - 3, 41 in stage 4, and 45 in stage 5. The mean (standard deviation) age was 67 (15) years, and 55% of patien

SUBMITTER: Jensen G 

PROVIDER: S-EPMC6434427 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature